Intraorbital amphotericin B for mucormycosis in an Allo-HSCT recipient

Bone Marrow Transplant. 2024 Aug;59(8):1176-1177. doi: 10.1038/s41409-024-02287-2. Epub 2024 Apr 25.

Authors

Wyatt Schwartz¹, Adam C Christiansen², Sagar S Patel²

Affiliations

¹ Transplant and Cellular Therapy Program, Huntsman Cancer Institute, University of Utah, Salt Lake City, USA. [email protected].
² Transplant and Cellular Therapy Program, Huntsman Cancer Institute, University of Utah, Salt Lake City, USA.

PMID: 38664590
DOI: 10.1038/s41409-024-02287-2

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adult
Allografts
Amphotericin B* / therapeutic use
Antifungal Agents / therapeutic use
Female
Hematopoietic Stem Cell Transplantation* / adverse effects
Humans
Male
Middle Aged
Mucormycosis* / drug therapy
Mucormycosis* / etiology

Substances

Amphotericin B
Antifungal Agents